At a glance
- Originator Pharmacia Corporation
- Class Antiarrhythmics; Nootropics; Vasodilators
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 22 Jun 2001 No-Development-Reported for Cognition disorders in Japan (Unknown route)
- 22 Jan 1997 Preclinical development for Cognition disorders in Japan (Unknown route)
- 19 Dec 1994 No-Development-Reported for Cognition disorders in Japan (Unknown route)